Literature DB >> 30064936

Cervical cancer worldwide.

Mailinh Vu1, Jim Yu2, Olutosin A Awolude3, Linus Chuang2.   

Abstract

Cervical cancer is the fourth most common cancer among women globally. The burden faced by low- and middle-income countries is significantly greater than high-income countries. The disparity is a direct result of the differences in resources. Developed nations have organized vaccination and screening programs that have decreased their cervical cancer incidence. More readily available personnel and technology exists to implement appropriate treatment modalities. However, for many underdeveloped nations, the scarcity of resources and infrastructure make such preventative and treatment programs limited or even nonexistent.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Disparity; Global; Low- and middle-income countries

Mesh:

Year:  2018        PMID: 30064936     DOI: 10.1016/j.currproblcancer.2018.06.003

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  121 in total

1.  MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/β-catenin signaling pathway.

Authors:  Tao Song; Xinghua Hou; Bing Lin
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

2.  Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia.

Authors:  Li Ping Wong; Pooi-Fong Wong; Megat Mohamad Amirul Amzar Megat Hashim; Liyuan Han; Yulan Lin; Zhijian Hu; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2020-05-19       Impact factor: 3.452

3.  Rational creation and systematic analysis of cervical cancer kinase-inhibitor binding profile.

Authors:  Min Han; Dongdong Sun
Journal:  J Comput Aided Mol Des       Date:  2019-06-15       Impact factor: 3.686

Review 4.  Intensified Systemic Therapy Regimens in Combination With Definitive Radiation for Treatment of Cervical Cancer.

Authors:  Travis T Sims; Ann H Klopp
Journal:  Semin Radiat Oncol       Date:  2020-10       Impact factor: 5.934

5.  Lidocaine inhibits cervical cancer cell proliferation and induces cell apoptosis by modulating the lncRNA-MEG3/miR-421/BTG1 pathway.

Authors:  Jinming Zhu; Shichao Han
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

6.  Racial/Ethnic Disparities in the Burden of HIV/Cervical Cancer Comorbidity and Related In-hospital Mortality in the USA.

Authors:  Hamisu Salihu; Deepa Dongarwar; Chioma A Ikedionwu; Andrea Shelton; China M Jenkins; Collins Onyenaka; Creaque Charles; Hongmei Wang; Inyang Osemene; Kiydra J Harris; Manvir Kaur; Monica Rasmus; Ololade Awosemo; Shirlette Milton; Sonnice Estill; Tolulope Adebusuyi; Xiuqing Gao; Ya Fatou N Mbye; Yuan Chen; Omonike A Olaleye
Journal:  J Racial Ethn Health Disparities       Date:  2020-05-06

7.  Indocyanine Green-Based Theranostic Nanoplatform for NIR Fluorescence Image-Guided Chemo/Photothermal Therapy of Cervical Cancer.

Authors:  Rong Ma; Nuernisha Alifu; Zhong Du; Shuang Chen; Youqiang Heng; Jing Wang; Lijun Zhu; Cailing Ma; Xueliang Zhang
Journal:  Int J Nanomedicine       Date:  2021-07-17

8.  Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis.

Authors:  Zhi-Min Deng; Fang-Fang Dai; Quan Zhou; Yan-Xiang Cheng
Journal:  BMC Cancer       Date:  2021-05-21       Impact factor: 4.430

9.  Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7-Expressing Carcinoma in the Cervicovaginal Tract.

Authors:  Talia R Henkle; Brandon Lam; Yu Jui Kung; John Lin; Ssu-Hsueh Tseng; Louise Ferrall; Deyin Xing; Chien-Fu Hung; T-C Wu
Journal:  Cancer Res       Date:  2021-07-02       Impact factor: 12.701

Review 10.  Cervical Cancer Surgery: Current State of Affairs.

Authors:  Fan Chun Yang; Wei Huang; Weihong Yang; Jie Liu; Guihai Ai; Ning Luo; Jing Guo; Peng Teng Chua; Zhongping Cheng
Journal:  Gynecol Minim Invasive Ther       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.